182 related articles for article (PubMed ID: 32476820)
1. Body Mass Index and arterial blood oxygenation as prognostic factors in patients with idiopathic pleuroparenchymal fibroelastosis.
Hayashi H; Nei T; Abe S; Saito Y; Kokuho N; Atsumi K; Fujita K; Saito T; Tanaka T; Gemma A; Azuma A
Sarcoidosis Vasc Diffuse Lung Dis; 2017; 34(1):35-40. PubMed ID: 32476820
[No Abstract] [Full Text] [Related]
2. Poorer Prognosis of Idiopathic Pleuroparenchymal Fibroelastosis Compared with Idiopathic Pulmonary Fibrosis in Advanced Stage.
Shioya M; Otsuka M; Yamada G; Umeda Y; Ikeda K; Nishikiori H; Kuronuma K; Chiba H; Takahashi H
Can Respir J; 2018; 2018():6043053. PubMed ID: 30186537
[TBL] [Abstract][Full Text] [Related]
3. Criteria for the diagnosis of idiopathic pleuroparenchymal fibroelastosis: A proposal.
Watanabe K; Ishii H; Kiyomi F; Terasaki Y; Hebisawa A; Kawabata Y; Johkoh T; Sakai F; Kondoh Y; Inoue Y; Azuma A; Suda T; Ogura T; Inase N; Homma S;
Respir Investig; 2019 Jul; 57(4):312-320. PubMed ID: 30981683
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of lung transplantation for idiopathic pleuroparenchymal fibroelastosis.
Shiiya H; Nakajima J; Date H; Chen-Yoshikawa TF; Tanizawa K; Handa T; Oto T; Otani S; Shiotani T; Okada Y; Matsuda Y; Shiraishi T; Moroga T; Minami M; Funaki S; Chida M; Yoshino I; Hatachi G; Uemura Y; Sato M
Surg Today; 2021 Aug; 51(8):1276-1284. PubMed ID: 33576927
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of lung elastic fibers in idiopathic pleuroparenchymal fibroelastosis (IPPFE): comparison of clinical, radiological, and pathological findings with those of idiopathic pulmonary fibrosis (IPF).
Enomoto N; Kusagaya H; Oyama Y; Kono M; Kaida Y; Kuroishi S; Hashimoto D; Fujisawa T; Yokomura K; Inui N; Nakamura Y; Suda T
BMC Pulm Med; 2014 May; 14():91. PubMed ID: 24886550
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis.
Kono M; Fujita Y; Takeda K; Miyashita K; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Enomoto N; Nakamura Y; Suda T; Nakamura H
Respir Med; 2019; 154():122-126. PubMed ID: 31238182
[TBL] [Abstract][Full Text] [Related]
7. Physiological Criteria Are Useful for the Diagnosis of Idiopathic Pleuroparenchymal Fibroelastosis.
Ikeda T; Kinoshita Y; Ueda Y; Sasaki T; Kushima H; Ishii H
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33266381
[TBL] [Abstract][Full Text] [Related]
8. Disease course and prognosis of pleuroparenchymal fibroelastosis compared with idiopathic pulmonary fibrosis.
Suzuki Y; Fujisawa T; Sumikawa H; Tanaka T; Sugimoto C; Kono M; Hozumi H; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
Respir Med; 2020 Sep; 171():106078. PubMed ID: 32917352
[TBL] [Abstract][Full Text] [Related]
9. Distinct profile and prognostic impact of body composition changes in idiopathic pulmonary fibrosis and idiopathic pleuroparenchymal fibroelastosis.
Suzuki Y; Yoshimura K; Enomoto Y; Yasui H; Hozumi H; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Nakamura Y; Inui N; Suda T
Sci Rep; 2018 Sep; 8(1):14074. PubMed ID: 30232390
[TBL] [Abstract][Full Text] [Related]
10. Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia.
Sugino K; Ono H; Shimizu H; Kurosawa T; Matsumoto K; Ando M; Mori K; Tsuboi E; Homma S; Kishi K
ERJ Open Res; 2021 Jan; 7(1):. PubMed ID: 33681342
[TBL] [Abstract][Full Text] [Related]
11. Determinants of Six-Minute Walk Distance in Idiopathic Pulmonary Fibrosis and Idiopathic Pleuroparenchymal Fibroelastosis.
Sato N; Iwanami Y; Ebihara K; Nakao K; Miyagi M; Nakamura Y; Kishi K; Homma S; Ebihara S
Biomedicines; 2022 Oct; 10(10):. PubMed ID: 36289817
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of idiopathic pleuroparenchymal fibroelastosis with progressive phenotype showing a decline in forced vital capacity.
Kono M; Tsunoda T; Ikeda S; Yagi S; Hirama R; Watanuki M; Oshima Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
Respir Investig; 2023 Mar; 61(2):210-219. PubMed ID: 36773509
[TBL] [Abstract][Full Text] [Related]
13. Limited efficacy of nintedanib for idiopathic pleuroparenchymal fibroelastosis.
Kinoshita Y; Miyamura T; Ikeda T; Ueda Y; Yoshida Y; Kushima H; Ishii H
Respir Investig; 2022 Jul; 60(4):562-569. PubMed ID: 35398003
[TBL] [Abstract][Full Text] [Related]
14. Usual Interstitial Pneumonia Pattern in the Lower Lung Lobes as a Prognostic Factor in Idiopathic Pleuroparenchymal Fibroelastosis.
Kato M; Sasaki S; Kurokawa K; Nakamura T; Yamada T; Sasano H; Arano N; Komura M; Ihara H; Nagashima O; Shiota S; Takahashi F; Takahashi K
Respiration; 2019; 97(4):319-328. PubMed ID: 30522096
[TBL] [Abstract][Full Text] [Related]
15. Differences Between Patients With Idiopathic Pleuroparenchymal Fibroelastosis and Those With Other Types of Idiopathic Interstitial Pneumonia in Candidates for Lung Transplants.
Shiiya H; Tian D; Sato M; Karasaki T; Kitano K; Nagayama K; Anraku M; Kaga K; Matsui Y; Nakajima J
Transplant Proc; 2019; 51(6):2014-2021. PubMed ID: 31303415
[TBL] [Abstract][Full Text] [Related]
16. Remodeling of the pulmonary artery in idiopathic pleuroparenchymal fibroelastosis.
Kinoshita Y; Ishii H; Kushima H; Johkoh T; Yabuuchi H; Fujita M; Nabeshima K; Watanabe K
Sci Rep; 2020 Jan; 10(1):306. PubMed ID: 31941942
[TBL] [Abstract][Full Text] [Related]
17. Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia.
Yamagata A; Arita M; Tachibana H; Tokioka F; Sugimoto C; Sumikawa H; Tanaka T; Yasui H; Fujisawa T; Nakamura Y; Suda T; Ishida T
Respir Res; 2021 Apr; 22(1):115. PubMed ID: 33879137
[TBL] [Abstract][Full Text] [Related]
18. The pathogenesis and pathology of idiopathic pleuroparenchymal fibroelastosis.
Kinoshita Y; Ishii H; Nabeshima K; Watanabe K
Histol Histopathol; 2021 Mar; 36(3):291-303. PubMed ID: 33315234
[TBL] [Abstract][Full Text] [Related]
19. Is hypothyroidism in idiopathic pleuroparenchymal fibroelastosis a novel lung-thyroid syndrome?
Awano N; Izumo T; Fukuda K; Tone M; Yamada D; Takemura T; Ikushima S; Kumasaka T
Respir Investig; 2018 Jan; 56(1):48-56. PubMed ID: 29325681
[TBL] [Abstract][Full Text] [Related]
20. Partial pressure of carbon dioxide levels reflect disease severity in idiopathic pleuroparenchymal fibroelastosis.
Kinoshita Y; Utsunomiya T; Koide Y; Wada K; Ueda Y; Yoshida Y; Kushima H; Ishii H
Respir Investig; 2023 Jul; 61(4):379-386. PubMed ID: 37079943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
